Stocktoria
Rezolute, Inc. RZLT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2011-12-23
Rezolute, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Evans Daron | CFO | 2026-03-30 | Buy | 10,000 | $2.85 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | 2026-03-02 | Tax withheld | 11,439 | $2.99 |
| Evans Daron | CFO | 2026-03-02 | Tax withheld | 11,438 | $2.99 |
| Elam Nevan C | CEO | 2026-03-02 | Tax withheld | 27,618 | $2.99 |
| Hogenhuis Wladimir | director | 2025-12-16 | Buy | 5,650 | $1.69 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | 2025-12-16 | Buy | 28,000 | $1.70 |
| Evans Daron | CFO | 2025-12-15 | Buy | 40,000 | $1.77 |
| Evans Daron | CFO | 2025-12-15 | Buy | 2,500 | $1.78 |
Source: SEC EDGAR filings · CIK 0001509261 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.